Goldman Sachs’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,150
Closed -$1.3M 7246
2014
Q4
$1.3M Buy
+1,150
New +$1.18M ﹤0.01% 4278
2014
Q3
Sell
-1,500
Closed -$1.98M 7232
2014
Q2
$1.98M Buy
+1,500
New +$1.8M ﹤0.01% 4005
2014
Q1
Sell
-9,082
Closed -$10.4M 6896
2013
Q4
$10.4M Hold
9,082
﹤0.01% 2330
2013
Q3
$11.4M Buy
+9,082
New +$6.16M ﹤0.01% 2119

Other funds holding RMTI

Goldman Sachs's RMTI Position: Q2 2025 in Review

Goldman Sachs sold out of Rockwell Medical (RMTI) in Q2 2025, closing a stake of 4,012 shares — an estimated $45.3K sold.

Goldman Sachs first reported a position in RMTI in Q3 2013 and held it in 31 quarters. The position peaked at $3.24M in Q2 2014. 41 funds tracked by Wall St. Rank hold RMTI as of Q2 2025.

  • Goldman Sachs reported no remaining Rockwell Medical position as of Q2 2025 after selling out during the quarter.
  • Goldman Sachs sold 4,012 Rockwell Medical shares in Q2 2025, an estimated $45.3K.
  • Goldman Sachs first reported a position in Rockwell Medical in Q3 2013 and held it in 31 quarters.
  • Goldman Sachs's Rockwell Medical position peaked at $3.24M in Q2 2014.
  • 41 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2025.

Based on Goldman Sachs's 13F filing for Q2 2025, filed 14 Aug 2025.